Oct 2026· Frontiers in Medicine· Vol 13· 0 citations· 115 references
TL;DR
The utilization of multimodal data by AI models to enhance diagnostic accuracy, evaluate disease progression, and optimize personalized care strategies is investigated to highlight AI's growing potential to revolutionize MS diagnosis.
Abstract
Multiple Sclerosis (MS) is an immune-mediated central nervous system condition with heterogeneous clinical manifestations, progressive neurodegeneration, and considerable variability in disease trajectory. Recent advances in artificial intelligence (AI), particularly machine learning (ML) methods, have improved MS diagnosis and risk prediction. However, comprehensive review studies emphasizing the potential of existing AI-powered MS diagnosis remain limited. Thus, this study investigates the utilization of multimodal data by AI models to enhance diagnostic accuracy, evaluate disease progression, and optimize personalized care strategies. By adhering to PRISMA guidelines, this review included 26 studies encompassing MRI-based analysis, retinal OCT imaging, blood transcriptomics, SNP genotyping, and multimodal clinical datasets. An additional classification of these studies by modality was performed, and they were assessed with respect to dataset size, performance metrics, biomarkers, methodological robustness, and model interpretability. The findings indicate a consistent trend toward outstanding diagnostic performance, with some AI models achieving accuracies exceeding 95% using medical imaging and genomic data. However, limited external validation and interpretability procedures create a gap in clinical applicability and trustworthiness. This review highlights AI's growing potential to revolutionize MS diagnosis.
Central nervous system (CNS) autoimmune diseases, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), remain difficult to diagnose, stratify, and treat because clinical phenotypes ov...
Findings varied across datasets, tasks, validation procedures, and populations, while high accuracies were often derived from curated datasets and internal validation, which restrict clinical generalizability.
This paper synthesizes recent advancements in the application of machine learning on blood biomarker analysis, evaluating their diagnostic efficacy and clinical translational potential and proposes a scalable “Step-Care” framework that transitions from single-biomarker community screening to precise multimodal fusion,...
Lin-Hong Xu, Jian-Bo Tu, Ji-Peng Zhang et al.· Frontiers in Aging Neuroscie...· 0 citations
Artificial intelligence-enabled approaches show promise for earlier and more objective ALS detection, but the current literature is dominated by small, retrospective, single-site studies.
Dhinesh Selvaraju, Kishore Durairaj, Krishna Ravi· The Egyptian Journal of Neur...· 0 citations
Artificial intelligence (AI) is being applied across diagnostic and therapeutic workflows in hepatology. This narrative review summarizes recent advances in AI for liver disease. In medical imaging and digital pathology, computer vision enables automated quantitative analysis of ultrasound, CT, MRI, and histologic imag...
Ze-Kai Hu, Ya-Jie Lin, Hainv Gao et al.· Frontiers in Digital Health· 0 citations
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, where traditional diagnostic methods are constrained by limited sensitivity and restricted clinical utility. This review synthesizes recent applications of artificial intelligence (AI) in AD diagnostics, focusing on machine learning (ML) and deep lea...
En-Qi Liu, Mei-Jia Cheng, Ye-Tao Ju et al.· Frontiers in Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.